Melissa Konken
Psychiatric/Mental Health · Sioux City, IANPI 1902358443
Payments from drug & device makers
Across 845 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$2K
- Neurocrine Biosciences, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$1K
- plus $5K from 17 others
What the payments were for
- Food & beverage$13,74299%
- Education$1461%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 97 | $1,969 |
| Neurocrine Biosciences, Inc. | 116 | $1,597 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 103 | $1,593 |
| AbbVie | 111 | $1,346 |
| Otsuka America Pharmaceutical, Inc. | 79 | $1,286 |
| Teva Pharmaceuticals USA, Inc. | 57 | $1,153 |
| Johnson & Johnson | 54 | $980 |
| Vanda Pharmaceuticals Inc. | 39 | $971 |
| Corium, LLC | 59 | $682 |
| E.r. Squibb & Sons, L.L.C. | 32 | $652 |
| Lundbeck LLC | 25 | $418 |
| Supernus Pharmaceuticals, Inc. | 13 | $310 |
| Sunovion Pharmaceuticals Inc. | 12 | $177 |
| Ironshore Pharmaceuticals Inc. | 14 | $174 |
| Indivior Inc. | 10 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $132 |
| Axsome Therapeutics, Inc. | 2 | $77 |
| Tris Pharma Inc | 3 | $71 |
| Merck | 4 | $57 |
| Noven Therapeutics, LLC | 3 | $45 |
| Eisai Inc. | 2 | $31 |
| Almatica Pharma LLC | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$960
- ARISTADA$452
- COBENFY$250
- REXULTI$237
- QELBREE$214
- INVEGA TRINZA$118
- UZEDY$116
- SPRAVATO$115
- Fanapt$114
- ARISTADA INITIO$113
- INVEGA SUSTENNA$109
How this compares
$13,887 in reported general payments places this provider in the 95th percentile of 443 psychiatric/mental health providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 80 | $656,745 |
| Invega SustennaPaliperidone Palmitate | 73 | $227,779 |
| Invega TrinzaPaliperidone Palmitate | 18 | $134,369 |
| RexultiBrexpiprazole | 89 | $130,754 |
| CaplytaLumateperone Tosylate | 73 | $115,585 |
| FanaptIloperidone | 52 | $89,162 |
| Austedo XrDeutetrabenazine | 17 | $86,672 |
| AristadaAripiprazole Lauroxil | 24 | $79,469 |
| Abilify AsimtufiiAripiprazole | 14 | $70,982 |
| VraylarCariprazine Hcl | 24 | $26,254 |
| TrintellixVortioxetine Hydrobromide | 54 | $25,332 |
| BelsomraSuvorexant | 49 | $23,688 |
| Paliperidone ErPaliperidone | 137 | $19,838 |
| SeroquelQuetiapine Fumarate | 11 | $18,877 |
| Divalproex Sodium ErDivalproex Sodium | 445 | $18,149 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,597 | $656,74580 claims |
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $980 | $362,14791 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Asimtufii | $1,286 | $201,736103 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,593 | $115,58573 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $971 | $89,16252 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $1,153 | $86,67217 claims |
| Alkermes, Inc.Aristada | $1,969 | $79,46924 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $132 | $37,55391 claims |
| AbbVieVraylar | $1,346 | $26,25424 claims |
| MerckBelsomra | $57 | $23,68849 claims |
| Corium, LLCAzstarys | $682 | $8,87622 claims |
| Eisai Inc.Dayvigo | $31 | $3,85517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Sioux City
- Ricardo OsorioSioux City$8K
- Brenda CainSioux City$6K
- Danika HansenSioux City$5K
- Erin HodgsonSioux City$4K
- Joada BestSioux City$4K
- Tyler LeskoSioux City$4K
- Cynthia GuthmillerSioux City$4K
- Monica NuckollsSioux City$4K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.